
Michael A. Neas
Examiner (ID: 7597)
| Most Active Art Unit | 2407 |
| Art Unit(s) | PCT, 2407, 3741, 3765, 3408, DCIPC |
| Total Applications | 972 |
| Issued Applications | 837 |
| Pending Applications | 58 |
| Abandoned Applications | 80 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5596268
[patent_doc_number] => 20060160185
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-20
[patent_title] => 'METHODS OF EVALUATING VIRAL ENTRY INHIBITORS USING PATIENT DERIVED ENVELOPE PROTEIN CONSTRUCTS'
[patent_app_type] => utility
[patent_app_number] => 11/323189
[patent_app_country] => US
[patent_app_date] => 2005-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 24191
[patent_no_of_claims] => 72
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20060160185.pdf
[firstpage_image] =>[orig_patent_app_number] => 11323189
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/323189 | Methods of evaluating viral entry inhibitors using patient derived envelope protein constructs | Dec 28, 2005 | Issued |
Array
(
[id] => 637728
[patent_doc_number] => 07125712
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-10-24
[patent_title] => 'Bovine immunodeficiency virus (BIV) based vectors'
[patent_app_type] => utility
[patent_app_number] => 11/076498
[patent_app_country] => US
[patent_app_date] => 2005-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 17434
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/125/07125712.pdf
[firstpage_image] =>[orig_patent_app_number] => 11076498
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/076498 | Bovine immunodeficiency virus (BIV) based vectors | Mar 7, 2005 | Issued |
Array
(
[id] => 7460477
[patent_doc_number] => 20040052821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-18
[patent_title] => 'HIV envelope polypeptides and vaccine'
[patent_app_type] => new
[patent_app_number] => 10/371472
[patent_app_country] => US
[patent_app_date] => 2003-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 32043
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20040052821.pdf
[firstpage_image] =>[orig_patent_app_number] => 10371472
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/371472 | HIV envelope polynucleotides and immunogenic composition | Feb 20, 2003 | Issued |
Array
(
[id] => 739971
[patent_doc_number] => 07029682
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-04-18
[patent_title] => 'Inactivated vaccine against feline calicivirosis'
[patent_app_type] => utility
[patent_app_number] => 10/368861
[patent_app_country] => US
[patent_app_date] => 2003-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6028
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/029/07029682.pdf
[firstpage_image] =>[orig_patent_app_number] => 10368861
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/368861 | Inactivated vaccine against feline calicivirosis | Feb 17, 2003 | Issued |
Array
(
[id] => 668314
[patent_doc_number] => 07094553
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-08-22
[patent_title] => 'Antibodies specific for ungulate PrP'
[patent_app_type] => utility
[patent_app_number] => 10/355780
[patent_app_country] => US
[patent_app_date] => 2003-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 13
[patent_no_of_words] => 18623
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/094/07094553.pdf
[firstpage_image] =>[orig_patent_app_number] => 10355780
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/355780 | Antibodies specific for ungulate PrP | Jan 29, 2003 | Issued |
| 10/311581 | Nucleotide sequence of influenza a/udorn/72 (h3n2) genome | Dec 15, 2002 | Abandoned |
Array
(
[id] => 6658333
[patent_doc_number] => 20030133948
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-17
[patent_title] => 'Methods to inhibit or enhance the binding of viral DNA to genomic host DNA'
[patent_app_type] => new
[patent_app_number] => 10/294804
[patent_app_country] => US
[patent_app_date] => 2002-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 12721
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0133/20030133948.pdf
[firstpage_image] =>[orig_patent_app_number] => 10294804
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/294804 | Methods to inhibit or enhance the binding of viral DNA to genomic host DNA | Nov 13, 2002 | Abandoned |
Array
(
[id] => 7448585
[patent_doc_number] => 20040009909
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-15
[patent_title] => 'Methods for inhibiting lentivirus replication'
[patent_app_type] => new
[patent_app_number] => 10/285263
[patent_app_country] => US
[patent_app_date] => 2002-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13602
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20040009909.pdf
[firstpage_image] =>[orig_patent_app_number] => 10285263
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/285263 | Methods of identifying agents for inhibiting lentivirus replication | Oct 29, 2002 | Issued |
Array
(
[id] => 671825
[patent_doc_number] => 07090852
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-08-15
[patent_title] => 'Venezuelan equine encephalitis virus replicon encoding marburg virus proteins'
[patent_app_type] => utility
[patent_app_number] => 10/267322
[patent_app_country] => US
[patent_app_date] => 2002-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 9065
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/090/07090852.pdf
[firstpage_image] =>[orig_patent_app_number] => 10267322
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/267322 | Venezuelan equine encephalitis virus replicon encoding marburg virus proteins | Oct 8, 2002 | Issued |
Array
(
[id] => 686329
[patent_doc_number] => 07078044
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-07-18
[patent_title] => 'Anti-amoebic vaccine'
[patent_app_type] => utility
[patent_app_number] => 10/263947
[patent_app_country] => US
[patent_app_date] => 2002-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 8363
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/078/07078044.pdf
[firstpage_image] =>[orig_patent_app_number] => 10263947
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/263947 | Anti-amoebic vaccine | Oct 2, 2002 | Issued |
| 09/671724 | Novel retroviral constructs | Oct 2, 2002 | Abandoned |
Array
(
[id] => 7220342
[patent_doc_number] => 20040072236
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-15
[patent_title] => 'PrPSc -interacting molecules and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/256538
[patent_app_country] => US
[patent_app_date] => 2002-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11147
[patent_no_of_claims] => 85
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20040072236.pdf
[firstpage_image] =>[orig_patent_app_number] => 10256538
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/256538 | PrPSc -interacting molecules and uses thereof | Sep 26, 2002 | Abandoned |
Array
(
[id] => 6778591
[patent_doc_number] => 20030049672
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-13
[patent_title] => 'Methods and compositions for regulating protein-protein interactions'
[patent_app_type] => new
[patent_app_number] => 10/256865
[patent_app_country] => US
[patent_app_date] => 2002-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 20362
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20030049672.pdf
[firstpage_image] =>[orig_patent_app_number] => 10256865
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/256865 | Methods and compositions for regulating protein-protein interactions | Sep 25, 2002 | Abandoned |
Array
(
[id] => 676565
[patent_doc_number] => 07087740
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-08-08
[patent_title] => 'Kits for use in detecting resistance to streptogramin A and related compounds'
[patent_app_type] => utility
[patent_app_number] => 10/253904
[patent_app_country] => US
[patent_app_date] => 2002-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 14
[patent_no_of_words] => 11672
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/087/07087740.pdf
[firstpage_image] =>[orig_patent_app_number] => 10253904
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/253904 | Kits for use in detecting resistance to streptogramin A and related compounds | Sep 24, 2002 | Issued |
Array
(
[id] => 1049761
[patent_doc_number] => 06861059
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-03-01
[patent_title] => 'Methods and compositions for treatment of HIV-1 infection using antiviral compounds in simultaneous or sequential combinations'
[patent_app_type] => utility
[patent_app_number] => 10/252136
[patent_app_country] => US
[patent_app_date] => 2002-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 17462
[patent_no_of_claims] => 113
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/861/06861059.pdf
[firstpage_image] =>[orig_patent_app_number] => 10252136
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/252136 | Methods and compositions for treatment of HIV-1 infection using antiviral compounds in simultaneous or sequential combinations | Sep 19, 2002 | Issued |
Array
(
[id] => 6782607
[patent_doc_number] => 20030064054
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-03
[patent_title] => 'Detection of human immunodeficiency virus using cells transduced with a complex viral vector'
[patent_app_type] => new
[patent_app_number] => 10/244140
[patent_app_country] => US
[patent_app_date] => 2002-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 24628
[patent_no_of_claims] => 69
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 161
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20030064054.pdf
[firstpage_image] =>[orig_patent_app_number] => 10244140
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/244140 | Compositions and methods for detecting human immunodeficiency virus | Sep 12, 2002 | Issued |
Array
(
[id] => 6766098
[patent_doc_number] => 20030100498
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-29
[patent_title] => 'Methods for increasing CD4+ T- lymphocyte counts in HIV-infected patients by the administration of GM-CSF'
[patent_app_type] => new
[patent_app_number] => 10/226086
[patent_app_country] => US
[patent_app_date] => 2002-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3717
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20030100498.pdf
[firstpage_image] =>[orig_patent_app_number] => 10226086
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/226086 | Methods for treating HIV-infected patients by the administration of GM-CSF and a protease inhibitor | Aug 20, 2002 | Issued |
Array
(
[id] => 6696375
[patent_doc_number] => 20030108569
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-12
[patent_title] => 'Novel recombinant and mutant adenoviruses'
[patent_app_type] => new
[patent_app_number] => 10/199520
[patent_app_country] => US
[patent_app_date] => 2002-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 13776
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20030108569.pdf
[firstpage_image] =>[orig_patent_app_number] => 10199520
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/199520 | Novel recombinant and mutant adenoviruses | Jul 18, 2002 | Abandoned |
Array
(
[id] => 6787532
[patent_doc_number] => 20030138771
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-24
[patent_title] => 'DNA sequences from S. pneumoniae bacteriophage DP1 that encode anti-microbal polypeptides'
[patent_app_type] => new
[patent_app_number] => 10/097111
[patent_app_country] => US
[patent_app_date] => 2002-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 38586
[patent_no_of_claims] => 84
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0138/20030138771.pdf
[firstpage_image] =>[orig_patent_app_number] => 10097111
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/097111 | DNA sequences from S. pneumoniae bacteriophage DP1 that encode anti-microbal polypeptides | Jul 16, 2002 | Abandoned |
Array
(
[id] => 6860586
[patent_doc_number] => 20030091594
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-15
[patent_title] => 'CD4-independent HIV envelope proteins as vaccines and therapeutics'
[patent_app_type] => new
[patent_app_number] => 10/196515
[patent_app_country] => US
[patent_app_date] => 2002-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 30890
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0091/20030091594.pdf
[firstpage_image] =>[orig_patent_app_number] => 10196515
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/196515 | CD4-independent HIV envelope proteins as vaccines and therapeutics | Jul 15, 2002 | Issued |